Current and Emerging Medications: the Pros and Cons for Patients, Clinicians and the PBS

Critical Issues in Juvenile Arthritis: Current Emerging Medications – Pros and cons for patients, clinicians and the PBS“ was held on 4 August, 2021. Top Australian paediatric rheumatologists explored the A to Z of available and emerging medicines for Juvenile Arthritis and the role of the Pharmaceutical Benefits Scheme (PBS).

Related Posts